The London-based medtech startup Mendelian is on the mission to improve the lives of patients by diagnosing rare diseases faster. Recently, the startup has received an endowment of €570k from Innovate UK. The financing will be employed in developing solutions enabling physicians to determine rare diseases.
Piers Ricketts, Chief Executive at the Eastern Academic Health Science Network said, “We are delighted to support Mendelian as part of our work into rare diseases. With over 3 million rare disease patients in the UK, innovative technologies using data analytics and machine learning like this are increasingly vital in ensuring that these conditions are diagnosed earlier to provide more targeted and personalised treatment for patients.”